Dogwood Therapeutics, Inc. ( DWTX) - Key Metrics
DWTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.34 | -$0.11 | -$0.11 |
| 2026Q1 | $0 | -$0.15 | -$0.14 | -$0.14 |
| 2025Q4 | $0 | -$0.26 | -$0.25 | -$0.25 |
| 2025Q3 | $0 | -$8.20 | -$1.71 | -$1.71 |
| 2025Q2 | $0 | -$2.64 | -$2.79 | -$2.79 |
DWTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.18 |
| 2026Q1 | 0% | -3.52 |
| 2025Q4 | 0% | -4 |
| 2025Q3 | 0% | -0.23 |
| 2025Q2 | 0% | -0.60 |
DWTX
Price: $1.25
52 week price:
Earnings Per Share: 1.96 USD
P/E Ratio: 1.09
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 49.1 million